Products
CELLULOX®
Target
Females
Problem Solving
CELLULOX® Donna is a Food Supplement, indicated to:
contrast cellulite imperfections (Edematous Fibrosclerotic Penniculopathy – EFP);
contribute to normal collagen formation for the function of blood vessels;
regulate the female microcirculation functionality.
Furthermore, it gives an important support to the maintenance of an healthy skin balance.
Characteristics
CELLULOX® is a food supplement containing Chitosan, Centella asiatica, and Vitamins:
Centella asiatica contrasts cellulite imperfections; Vitamin C contributes to normal collagen formation for the normal function of blood vessels; Vitamin B6 contributes to the regulation of hormonal activity; Riboflavin (Vitamin B2) contributes to the maintenance of normal skin.
Pack
30 tablets 580 mg
Daily Dose
2 tablets twice a day
Females
Problem Solving
CELLULOX® Donna is a Food Supplement, indicated to:
contrast cellulite imperfections (Edematous Fibrosclerotic Penniculopathy – EFP);
contribute to normal collagen formation for the function of blood vessels;
regulate the female microcirculation functionality.
Furthermore, it gives an important support to the maintenance of an healthy skin balance.
Characteristics
CELLULOX® is a food supplement containing Chitosan, Centella asiatica, and Vitamins:
Centella asiatica contrasts cellulite imperfections; Vitamin C contributes to normal collagen formation for the normal function of blood vessels; Vitamin B6 contributes to the regulation of hormonal activity; Riboflavin (Vitamin B2) contributes to the maintenance of normal skin.
Pack
30 tablets 580 mg
Daily Dose
2 tablets twice a day
PRINTABLE PAGE
FURTHER RESOURCES (RESERVED AREA)
SHARE THIS PAGEPOSTS
31/01/2023
Regolamento (EU) n. 536/2014 sulle sperimentazioni cliniche
Dopo il periodo di transizione, dalla data odierna 31 gennaio 2023 tutte le procedure di autorizzazione della sperimentazione clinica devono obbligatoriamente essere richieste segu...
read more
22/11/2022
Market Surveillance of Medical Devices
All manufacturers of medical devices (MDs) must minimize the risk posed by their MDs and ensure patient safety. Post-market surveillance is thus mandatory. According to the new MDR...
read more